Research graph
References from Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2008 · External reference
Investigation into the actual conditions about diabetic neuropathy
2001 · External reference
Diabetic neuropathies. A statement by the American Diabetes Association
10.2337/diacare.28.4.956 · 2005 · External reference
Sleep impairment in patients with painful diabetic peripheral neuropathy
10.1097/01.ajp.0000210910.49923.09 · 2006 · External reference
Diabetic neuropathies
10.1016/j.mcna.2004.04.009 · 2004 · External reference
Unresolved reference
2007 · External reference
A systematic review of antidepressants in neuropathic pain
10.1016/s0304-3959(96)03140-5 · 1996 · External reference
The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception
10.1016/0006-8993(93)90210-e · 1993 · External reference
Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry
10.1146/annurev.ne.07.030184.001521 · 1984 · External reference
Unresolved reference
1999 · External reference
Neurotransmitters in nociceptive modulatory circuits
10.1146/annurev.ne.14.030191.001251 · 1991 · External reference
Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain
10.1017/s0140525x97251484 · 1997 · External reference
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
10.1212/wnl.37.4.589 · 1987 · External reference
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
10.1016/j.pain.2008.02.024 · 2008 · External reference
Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states
10.2165/00002512-199608060-00008 · 1996 · External reference
Treatment of chronic pain with drugs that modulate central nervous system serotonin and norepinephrine
10.2174/157488507780619086 · 2007 · External reference
Dual serotonin and noradrenalin uptake inhibitor class of anti-depressants - potential for greater efficacy or just hype?
10.1007/978-3-0348-8183-8_5 · 2002 · External reference
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats
10.1124/jpet.104.070656 · 2004 · External reference
Duloxetine vs. placebo in patients with painful diabetic neuropathy
10.1016/j.pain.2005.03.029 · 2005 · External reference
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain
10.1111/j.1526-4637.2005.00061.x · 2005 · External reference
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
10.1212/01.wnl.0000240225.04000.1a · 2006 · External reference
Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain
10.1016/s0025-6196(11)61475-4 · 2006 · External reference
Pharmacologic management of neuropathic pain: evidence-based recommendations
10.1016/j.pain.2007.08.033 · 2007 · External reference
EFNS guidelines on pharmacological treatment of neuropathic pain
10.1111/j.1468-1331.2006.01511.x · 2006 · External reference
Unresolved reference
2010 · External reference
Phase I study of duloxetine - multiple dose study (60 mg once daily for 7 days)
2009 · External reference
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
10.1016/s0304-3959(01)00349-9 · 2001 · External reference
Abbreviated diagnostic criteria for distal symmetric polyneuropathy
2003 · External reference
Unresolved reference
1976 · External reference
Pain assessment: global use of the Brief Pain Inventory
1994 · External reference
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
2010 · External reference
The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA
10.1191/1740774504cn049oa · 2004 · External reference
The clinical importance of changes in the 0-10 Numeric Rating Scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders
10.1016/j.jpain.2009.06.007 · 2010 · External reference
Unresolved reference
2004 · External reference
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life
10.1016/s0168-8227(99)00112-6 · 2000 · External reference
A systematic review of the associations between dose regimens and medication compliance
10.1016/s0149-2918(01)80109-0 · 2001 · External reference
